Personalised Care
Regulatory Perspectives on the Thorough QT/QTc Study 2005 FDA/Industry Workshop Washington DC September 16, 2005 Juan (Joanne) Zhang, Ph.D. CDER/FDA *Acknowledgement:
Brain Volume Presentation for MS Bloggers
ABRAXANE EN CÁNCER DE MAMA Lucía González-Cortijo Hospital Universitario Quirón Madrid Madrid, 11 de febrero de 2015.
The effects of low magnitude high frequency mechanical stimulation (LMS) on bone density in childhood cancer survivors (CCS). Kirsten K. Ness, PT, PhD.
NIH/NINDS: 1R01NS071867 PI: Michael Frankel Emory University.
Recruitment and Retention for Diabetes Prevention Carol Percy, RN, MS Shiprock DPPOS Program Coordinator Roz Barber Shiprock DPP Recruitment and Retention.
Lecture 2
Confounding, Effect Modification, and Stratification HRP 261 1/26/04.
Recruitment and Retention for CVD Risk Reduction Carol Percy, RN, MS Shiprock DPPOS Program Coordinator Mary Hoskin, RD, MS Phoenix DPPOS Program Coordinator.
Regulatory Perspectives on the Thorough QT/QTc Study
